Top Pharmaceuticals Foreign Direct Investment Companies
Powered by
Unlock hidden opportunities in the Pharmaceuticals industry
Top Pharmaceuticals Foreign Direct Investment Companies report analyzes the most active greenfield FDI investors globally (based on number of projects) in the Pharmaceuticals sector between Q1 2019 and Q1 2024.
Additionally, the report highlights where these top Pharmaceuticals investors are investing in what type of operations. The report also provides an overview of notable FDI projects from these top investors.
The report will be delivered within 2-3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance.
Scope
Top Pharmaceuticals Foreign Direct Investment Companies report provides an overview of top greenfield foreign direct investment companies (based on number of projects) in the Pharmaceuticals sector between Q1 2019 and Q1 2024. This report takes a close look at the top FDI investors in the Pharmaceuticals sector and identifies their key investment trends.
The scope of the research includes –
- Top 10 Pharmaceuticals investors – Where are they investing?
- Top 10 Pharmaceuticals investors – In which subsectors are they investing?
- Top 10 Pharmaceuticals investors – Key themes driving their investments
- Top 10 Pharmaceuticals investors – list of key FDI projects
Key Highlights
Bayer AG has been the most active pharmaceuticals greenfield investor between Q1 2019 and Q3 2023, according to GlobalData’s FDI Projects Database. The parent company has been actively investing through several of its subsidiaries/company divisions. The majority of Bayer AG investments were in the drug manufacturers subsector. In fact, 71.2% of its total foreign investments were in this subsector. It also created projects across a further 8 subsectors. The company has been active across eight world regions, mainly focused on Asia which received 27.1% of the company’s greenfield investments between Q1 2019 and Q3 2023. Other leading FDI project generators in the pharmaceuticals industry include Novartis AG, AstraZeneca Plc, E. Merck KG and Sanofi.
Reasons to Buy
- Identify who are the most active foreign investors in Pharmaceuticals industry
- Gain insights into where these Pharmaceuticals foreign investors are investing with city level details
- Understand the types of FDI projects the top Pharmaceuticals foreign investors are undertaking and their reasons for doing so